Opendata, web and dolomites

ICA-100

A NOVEL NON-INVASIVE SOLUTION FOR CONTINUOUS BLOOD PRESSURE MONITORING

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ICA-100 project word cloud

Explore the words cloud of the ICA-100 project. It provides you a very rough idea of what is the project "ICA-100" about.

decades    patients    read    monitor    frame    none    regarded    validated    certified    feasibility    hypertensive    patient    icaria    international    catheter    attempts    hospital    monitoring    655m    sphygmomanometers    massive    blood    accuracy    intensive    regarding    invasive    continuous    line    strategy    ica    solutions    operate    granting    capability    volunteers    marketing    healthy    simplicity    limitations    positive    financial    performance    recalibrations    pressure    protected    diastolic    regulatory    commercialise    obvious    icu    hyper    serious    tension    completing    standard    care    hitherto    gold    technique    thoroughly    deployment    obtaining    undertaken    limited    episodes    device    plan    mercury    despite    ing    movements    framework    freedom    arterial    hemodynamically    individuals    3b    accurate    influence    besides    complications    systolic    purpose    follow    relative    unstable    hypo    frequent    patents    obstacles    risks    poor    units    solution    trl5    poses    effect    market    severe    tracking    critical    periodic   

Project "ICA-100" data sheet

The following table provides information about the project.

Coordinator
ICARIA MEDICAL S.L. 

Organization address
address: PZ PAU VILA, 1 PLANTA 2, PUERTA 2C EDIFICI PALAU DE MAR 2C
city: BARCELONA
postcode: 8039
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website https://www.icariamed.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ICARIA MEDICAL S.L. ES (BARCELONA) coordinator 50˙000.00

Map

 Project objective

Blood pressure follow-up is essential in managing hemodynamically unstable patients at Intensive Care Units (ICU). Traditionally, mercury sphygmomanometers have been used for this purpose, and are regarded as the gold standard for Blood Pressure measurement. Despite the relative simplicity of the technique, sphygmomanometers have obvious limitations regarding accuracy and tracking capability, especially crucial for hospital patients. In the most critical patients the invasive arterial line catheter must be used, which however poses serious risks for severe complications. Over the past decades, several attempts have been undertaken to develop an effective, accurate and reliable solutions to continuously monitor blood pressure in a non-invasive way. Hitherto, none of the solutions under development have achieved a massive market deployment. Major obstacles for the implementation of state-of-the-art solutions are related to their limited performance, resulting in poor accuracy in hypo/hyper tension episodes, influence of patient movements on the system response, and need for periodic and frequent recalibrations. ICARIA has developed a solution for blood pressure monitoring (ICA-100) based on a novel operating principle that allows obtaining an accurate diastolic and systolic Blood Pressure read-out. The ICA-100 has already been validated in healthy volunteers (TRL5). The technology is protected by two international patents, granting ICARIA freedom-to-operate. In the frame of this Phase 1 Project we aim to further develop our marketing strategy and financial plan. Besides, we aim to assess thoroughly the relevant regulatory and legal framework for the Project. After completing this feasibility study, we plan to develop and commercialise a certified device for Continuous Non-Invasive Blood Pressure monitoring. Having a positive impact in 655m hospital patients and a potential favourable effect on 1.3b hypertensive individuals, from which only 1 in 5 is under control.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ICA-100" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ICA-100" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

Plasmanorg (2019)

Environmental-friendly organic chemical synthesis in plasma reactor

Read More  

Genetta (2019)

Pole climbing solution to improve safety at work and to prevent fatal accidents in industrial climbing

Read More